Effect of fish oil on pregnancy outcomes
Phase 2
- Conditions
- Condition 1: pre-eclampsia. Condition 2: eclampsia. Condition 3: gestational diabets mellitus. Condition 4: preterm laber.Pre-eclampsia, unspecifiedEclampsia in pregnancyDiabetes mellitus in pregnancy, unspecifiedPreterm spontaneous labour with preterm delivery
- Registration Number
- IRCT2015072123269N1
- Lead Sponsor
- Vice Chancellor for Research of Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 360
Inclusion Criteria
pregnant women aged between 18-35 years old; singleton pregnancy; being in 16th -20th weeks of gestational age; lack of preterm labor history; lack of infertility history.
Exclusion criteria: BMI>30; sensivity to fish and fish oil; being smoker or addict.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method enght of pregnancy. Timepoint: delivery. Method of measurement: week.;Preterm laber. Timepoint: child brith. Method of measurement: week.;Gestational diabets mellitus. Timepoint: 24-28 week. Method of measurement: laboratory test.;Newborn weight. Timepoint: child birth. Method of measurement: by means of newborn scale / gram.;Pre-eclampsia. Timepoint: after 20 week of pregnancy until child birth. Method of measurement: Blood pressure measurment and evaluation of proteinuria.;Eclampsia. Timepoint: seizure. Method of measurement: clinical signs.
- Secondary Outcome Measures
Name Time Method BMI. Timepoint: before pregnancy. Method of measurement: using measurement of height and weight.;Age. Timepoint: at initiation of the study. Method of measurement: year.;Education. Timepoint: at initiation of the study. Method of measurement: question and answer.;Parity. Timepoint: at initiation of the study. Method of measurement: the number of pregnancy.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do omega-3 fatty acids in fish oil modulate inflammatory pathways to prevent pre-eclampsia and gestational diabetes in IRCT2015072123269N1?
Does fish oil supplementation in IRCT2015072123269N1 outperform standard-of-care interventions for preterm labor and eclampsia management?
Which biomarkers, such as TNF-alpha or IL-6, correlate with fish oil efficacy in reducing pregnancy complications in IRCT2015072123269N1?
What are the safety profiles and management strategies for fish oil-related adverse events in high-risk pregnancies per IRCT2015072123269N1?
How does fish oil compare to metformin or calcium channel blockers in addressing gestational diabetes and pre-eclampsia in phase II trials?